Read More

Infection-Focused Barinthus Bio’s VTP-200 Data Underwhelming: Analyst Weighs On Mixed Perspectives

Explore the latest findings from Barinthus Biotherapeutics on VTP-200's performance in the APOLLO trial for low-grade cervical lesions linked to persistent hrHPV infection. Positive trends were noted, though not statistically significant. No major safety concerns were observed.

BRNS

Read More

Studies Led By Harvard Pilgrim Health Care Institute, HCA Healthcare And The University Of California, Irvine Announce Two Clinical Trials Identified A Better Way To Target Appropriate Antibiotics For Patients Hospitalized With Pneumonia Or Urinary Tra…

Algorithm driven alerts help identify best antibiotic for patients with common infections in two 59-hospital trials, with implications to reduce antibiotic resistanceTwo large multi-state studies uncovered a highly

HCA